A second study analyzed TRPM2 expression in the Tumor Immune Estimation Resource (TIMER) and Gene Expression Profiling and Interactive Analysis (GEPIA) databases: TRPM2 mRNA was elevated in ccRCC compared to non-neoplastic kidney, and TRPM2 upregulation predicted poor survival [219]. Here, TRPM2 is linked to nonpapillary renal cell carcinoma.